Trial NCT00437073

View at ClinicalTrials.gov 
Org. Study IDs: 107671

Last trial update was posted on 2015-10-15

MeSH Interventions

Capecitabine Lapatinib Topotecan

MeSH Conditions

Brain Neoplasms Breast Neoplasms Neoplasm Metastasis

Other Conditions

Neoplasms, Breast

Stopping Reasons

Lapatinib-topotecan arm enrollment closed early per protocol amendment 2. Then enrollment into remaining arm terminated due to operational issues.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID